N, Á., A, M., S, D., R, C., L, R., M, R., . . . R, A. (2024). Detection of minimal residual disease in acute myeloid leukemia: Evaluating utility and challenges. Frontiers in immunology, 15, 1252258. https://doi.org/10.3389/fimmu.2024.1252258
Chicago Style (17th ed.) CitationN, Álvarez, et al. "Detection of Minimal Residual Disease in Acute Myeloid Leukemia: Evaluating Utility and Challenges." Frontiers in Immunology 15 (2024): 1252258. https://doi.org/10.3389/fimmu.2024.1252258.
MLA (9th ed.) CitationN, Álvarez, et al. "Detection of Minimal Residual Disease in Acute Myeloid Leukemia: Evaluating Utility and Challenges." Frontiers in Immunology, vol. 15, 2024, p. 1252258, https://doi.org/10.3389/fimmu.2024.1252258.
Warning: These citations may not always be 100% accurate.